This Sources Sought opportunity from Department Of Health And Human Services was posted on March 15, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Patent Legal Services
Closed
FDA_1239036FederalSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
General Info
Agency
Department Of Health And Human Services → FDA Office Of The Chief ScientistView Agency
NAICS
541110 - Offices of LawyersView NAICS
Place of Performance
Silver Spring, MD, 20905, USASet-Aside
NONE
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyDepartment Of Health And Human Services → FDA Office Of The Chief Scientist
Contacts2 people available
OfficeSilver Spring, MD, 20993, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of The Chief Scientist
View Agency ProfileOffice AddressSilver Spring, MD, 20993, USA
Contacts
Full Description
Show more
FDA Sources Sought - Title: Patent Lega Services ID: 1239036 This is a Sources Sought Notice. The proposed North American Industry Classification System (NAICS) code for this acquisition is 541110. The purpose of this Sources Sought Announcement is to assist the Food and Drug Administration in conducting Market Research to identify sources of services that meet its requirements that are capable of providing Patent Legal Services for FDA Technologies that deal with the safety, efficacy, manufacture and security of: 1) food supply, nutrition and dietary supplements 2) drugs and biological therapeutics 3) medical devices and radiation emitting products 4) biologics including regulated products such as allergenics, blood and blood products, cellular & gene therapy products, tissue and tissue products, vaccines and xenotransplantion 5) animal and veterinary drugs and products, 6) tobacco products and 6) cosmetics FDA Technologies that require Patent Legal Services also include diagnostics and methods for the detection of pathogens, chemical agents and toxins, biomarker identification, bio-imaging, nanotechnology, software and personalized medicine. Interested offerors should submit their capability statement not exceeding fifteen (15) pages in length, excluding standard brochures. SUBMISSIONS ARE DUE no later than 12:00 pm, Eastern Time, March 25, 2021. The capabilities response shall be e-mailed to: Sharon.Masciana@fda.hhs.gov, and Anthony.Wimbush@fda.hhs.gov
